BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 31187164)

  • 21. Management of chronic pain in elderly, frail patients: finding a suitable, personalized method of control.
    Rastogi R; Meek BD
    Clin Interv Aging; 2013; 8():37-46. PubMed ID: 23355774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioids Resistance in Chronic Pain Management.
    Morrone LA; Scuteri D; Rombolà L; Mizoguchi H; Bagetta G
    Curr Neuropharmacol; 2017 Apr; 15(3):444-456. PubMed ID: 28503117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic pain and continuity of analgesic treatment during the COVID-19 pandemic.
    Valladales-Restrepo LF; Gaviria-Mendoza A; Machado-Duque ME; Prado-Echeverry JA; Cortés-Navarro JL; Machado-Alba JE
    Pain Pract; 2023 Apr; 23(4):359-367. PubMed ID: 36514870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropathic pain in cats: Mechanisms and multimodal management.
    Rusbridge C
    J Feline Med Surg; 2024 May; 26(5):1098612X241246518. PubMed ID: 38710218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Organic Small Molecules in Pain Management.
    Cuesta SA; Meneses L
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Genetic Polymorphisms in Chronic Pain Patients.
    Knezevic NN; Tverdohleb T; Knezevic I; Candido KD
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compounded Pain Formulations: What is the Evidence?
    Asbill S; Sweitzer SM; Spigener S; Romero-Sandoval A
    Int J Pharm Compd; 2024; 28(2):100-109. PubMed ID: 38604146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental Drugs for Neuropathic Pain.
    Salat K; Gryzlo B; Kulig K
    Curr Neuropharmacol; 2018; 16(8):1193-1209. PubMed ID: 29745335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In patients with chronic neuropathic pain, cannabinoids improve sleep and reduce pain vs. placebo.
    Kim J
    Ann Intern Med; 2023 May; 176(5):JC57. PubMed ID: 37126815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growing pain: striving for quality, relevance and applicability in Cochrane Reviews.
    Eccleston C; Wiffen P; Derry S; Moore A
    Cochrane Database Syst Rev; 2013 May; 2013(5):ED000059. PubMed ID: 23875191
    [No Abstract]   [Full Text] [Related]  

  • 31. Prediction of the Need for Anticonvulsants in the Management of Orofacial Neuropathic Pain Using Machine Learning.
    Suresh R; Yadalam PK; Ramadoss R; Ramalingam K
    Cureus; 2024 Apr; 16(4):e58934. PubMed ID: 38800307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Emerging Role of Quercetin in the Treatment of Chronic Pain.
    Liu C; Liu DQ; Tian YK; Mei W; Tian XB; Xu AJ; Zhou YQ
    Curr Neuropharmacol; 2022 Nov; 20(12):2346-2353. PubMed ID: 35959909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropathic Pain: Mechanisms, Sex Differences, and Potential Therapies for a Global Problem.
    Ghazisaeidi S; Muley MM; Salter MW
    Annu Rev Pharmacol Toxicol; 2023 Jan; 63():565-583. PubMed ID: 36662582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bridging the translational gap: adenosine as a modulator of neuropathic pain in preclinical models and humans.
    Arendt-Nielsen L; Klitgaard H; Hansen SN
    Scand J Pain; 2024 Jan; 24(1):. PubMed ID: 38070164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tumor-associated pain].
    Wirz S; Keßler J; Hofbauer H
    Schmerz; 2024 Feb; 38(1):57-69. PubMed ID: 38206419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pain management considerations in patients living with both pain syndromes and cardiovascular diseases and disorders.
    Leppien EE; Pauling EE; Smith E; Wisniewski B; Carpenter A; Schwier NC
    Pharmacotherapy; 2024 Feb; 44(2):184-196. PubMed ID: 38049207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances and challenges in neuropathic pain: a narrative review and future directions.
    Attal N; Bouhassira D; Colvin L
    Br J Anaesth; 2023 Jul; 131(1):79-92. PubMed ID: 37210279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-Quarter of People Manage Chronic Pain With Only Medication.
    Harris E
    JAMA; 2023 Dec; 330(23):2242. PubMed ID: 38019484
    [No Abstract]   [Full Text] [Related]  

  • 39. Combination Drug Therapy for the Management of Chronic Neuropathic Pain.
    Boccella S; De Filippis L; Giorgio C; Brandolini L; Jones M; Novelli R; Amorizzo E; Leoni MLG; Terranova G; Maione S; Luongo L; Leone M; Allegretti M; Minnella EM; Aramini A
    Biomolecules; 2023 Dec; 13(12):. PubMed ID: 38136672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IUPHAR review: Navigating the role of preclinical models in pain research.
    Karimi SA; Zahra FT; Martin LJ
    Pharmacol Res; 2024 Feb; 200():107073. PubMed ID: 38232910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.